This research is studying a new noninvasive device-based therapy called Transcutaneous Electrical Acustimulation (TEA) to learn about its safety and how well it works as a treatment of pain in chronic pancreatitis. The purpose of this study is to investigate the potential of TEA to treat abdominal pain in patients with chronic pancreatitis (CP). The study hypothesizes that TEA can be used as a non-pharmaceutical opioid-free approach to treat pain in chronic pancreatitis.
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Proportion of Approached Individuals Who Met Eligibility Criteria
Timeframe: Approximately 1 year (during the recruitment period)
Proportion of Approached and Eligible Participants Who Provided Informed Consent
Timeframe: Approximately 1 year (during the recruitment period)
Proportion of Participants Who Met the Eligibility Criteria After the run-in Period for the Participants Who Provided Informed Consent.
Timeframe: Approximately 2 weeks
Proportion of Participants Who Started the Intervention Among Those Who Met run-in Period Criteria.
Timeframe: Baseline visit (V1)
Proportion of Participants That Adhere to the Intervention as Prescribed Among Participants That Start the Intervention
Timeframe: Weeks 1-4 (after the 4-week treatment period)
Proportion of Participants Who Completed Follow up Visit at 4 Weeks and Return Complete Follow-up Questionnaires at Week 8, Among Participants Who Started the Intervention
Timeframe: Week 8
Median Interquartile Range (IQR) of the Time That it Takes to Complete Visit Number One
Timeframe: Baseline visit (V1)
Median Interquartile Range (IQR) of the Time That it Takes to Complete Visit Number Two
Timeframe: 4 weeks (after treatment period)
Proportion of Participants Who Came for Visit 1 and Completed All the Surveys Involved in the Study
Timeframe: Approximately 2 weeks
Percentage of Study Surveys That Were Completed Per Protocol
Timeframe: 8 weeks